Primary cutaneous cryptococcosis during therapy with methotrexate and adalimumab

Journal of Drugs in Dermatology

Volumn 7, Issue 1, 2008, Pages 53-54

  Wilson, Morgan L ^a   Sewell, Lindsay D ^a   Mowad, Christen M ^a  

^a GEISINGER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTIFUNGAL AGENT; ANTIRHEUMATIC AGENT; FLUCONAZOLE; HYDROXYCHLOROQUINE; METHOTREXATE; MONOCLONAL ANTIBODY;

ARTICLE; CASE REPORT; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DERMATOMYCOSIS; DRUG EFFECT; FEMALE; FINGER INJURY; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; RHEUMATOID ARTHRITIS;

ANTIBODIES, MONOCLONAL; ANTIFUNGAL AGENTS; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DERMATOMYCOSES; FEMALE; FINGER INJURIES; FLUCONAZOLE; HUMANS; HYDROXYCHLOROQUINE; METHOTREXATE; MIDDLE AGED;

EID: 42949093686     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Listing J, Strangfeld A, Kary S, et al. Infections in patients with rheumatoid arthritis treated with biologic agents. Arthritis Rheum. 2005;52:3403-3412.
2. Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: Systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA. 2006;295:2275-2285.
3. True DG, Penmetcha M, Peckham SJ. Disseminated cryptococcal infection in rheumatoid arthritis treated with methotrexate and infliximab. J Rheumatol. 2002;29:1561-1563.
4. Hage CA, Wood KL, Winer-Muram HT, Wilson SJ, Sarosi G, Knox KS. Pulmonary cryptococcosis after initiation of anti-tumor necrosis factor-alpha therapy. Chest. 2003;124:2395-2397.
5. Arend SM, Kuijper EJ, Allaart CF, Muller WH, Van Dissel JT. Cavitating pneumonia after treatment with infliximab and prednisone. European Journal of Clinical Microbiology & Infectious Diseases. 2004;23:638-641.
6. Shrestha RK, Stoller JK, Honari G, Procop GW, Gordon SM. Pneumonia due to cryptococcus neoformans in a patient receiving infliximab: Possible zoonotic transmission from a pet cockatiel. Respir Care. 2004;49:606-608.
7. Gordon KB, Langley RG, Leonardi C, et al. Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: Double-blind, randomized controlled trial and open-label extension study. J Am Acad Dermatol. 2006;55:598-606.
8. Chayakulkeeree M, Perfect JR. Cryptococcosis. Infect Dis Clin North Am. 2006;20:507-544.
9. Neuville S, Dromer F, Morin O, Dupont B, Ronin O, Lortholary O. Primary cutaneous cryptococcosis: A distinct clinical entity. Clinical Infectious Diseases. 2003;36:337-347.
10. Werchniak AE, Baughman RD. Primary cutaneous cryptococcosis in an elderly man. Clinical & Experimental Dermatology. 2004;29:159-160.
11. Noble RC, Fajardo LF. Primary cutaneous cryptococcosis: Review and morphologic study. Am J Clin Pathol. 1972;57:13-22.
12. Revenga F, Paricio JF, Merino FJ, Nebreda T, Ramirez T, Martinez AM. Primary cutaneous cryptococcosis in an immunocompetent host: Case report and review of the literature. Dermatology. 2002;204:145-149.
13. Huffnagle GB, Toews GB, Burdick MD, et al. Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to cryptococcus neoformans. Journal of Immunology. 1996;157:4529-4536.
14. Herring AC, Lee J, McDonald RA, Toews GB, Huffnagle GB. Induction of interleukin-12 and gamma interferon requires tumor necrosis factor alpha for protective T1-cell-mediated immunity to pulmonary cryptococcus neoformans infection. Infection & Immunity. 2002;70:2959-2964.
15. Herring AC, Falkowski NR, Chen GH, McDonald RA, Toews GB, Huffnagle GB. Transient neutralization of tumor necrosis factor alpha can produce a chronic fungal infection in an immunocompetent host: Potential role of immature dendritic cells. Infection & Immunity. 2005;73:39-49.
16. Altz-Smith M, Kendall LG, Jr, Stamm AM. Cryptococcosis associated with low-dose methotrexate for arthritis. Am J Med. 1987;83:179-181.